ADC TOXICITY ATLAS
Payloads & linkers
Payload · Topoisomerase I inhibitor

DXd

TopoI inhibitor

CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C5[C@H](CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)CO)O
Physicochemistry

Properties

MW
493.5 Da
XLogP3
0
logD₇.₄
1.4
TPSA
129 Ų
pKa
9.2
Charge pH 7.4
+1
H-bond donors
3
H-bond acceptors
8
Bystander
Yes
PubChem CID
117888634
Bioactivity
Free DXd payload: TOP1 (DNA topoisomerase I) inhibitor; in vitro IC50 ~0.5 nM (MDA-MB-468) and ~4 nM (KPL-4) per ADCdb. T-DXd ADC IC50 0.7 ng/mL (SK-BR-3), 8.1 ng/mL (NCI-N87); cell-kill ranges ~0.7 to >3000 ng/mL by HER2 expression. Source: ADCdb PAY0UXDSB / DRG0ERKBH.
3 agents

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
Datopotamab deruxtecanTACSTD2
38
24
30
35
56
2.4
Trastuzumab deruxtecanERBB2
11
67
70
52
64
76
11
13
Patritumab deruxtecanERBB3
2.7
16.9
37.3
43.6
32.9
65.3
5.3
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed